Under a project development agreement signed between Sabic and Rongsheng Petrochemical, both the companies will work together to advance the development of the Jintang New Materials Project in Zhoushan, Zhejiang Province, China.

With an aim to become an AI-based, high-value materials company, LG Chem has plans to invest 9.7 billion dollars in R&D by 2035. The firm will also focus on semiconductor, mobility, and robotics materials.

Nuberg EPC has designed and supplied a 100–150 TPD Emergency Chlorine Absorption System for Brinsa in Bogotá, Colombia. The project is scheduled for commissioning in October 2026.

Charbone has delivered its electrolyzer to the Company's flagship Sorel-Tracy site. This move makes it one of the most significant physical milestones to date in the development of Phase 1B.

Ineos Inovyn has decided to acquire the remaining 50 % shareholding in Runcorn MCP, a firm owned by Vynova Runcorn. With this deal, Ineos Inovyn aims to strengthen the continuity of strategically critical chlor‑alkali operations in the UK, underpinning water treatment, chemicals production and food manufacturing.

Under a MOU signed between Ineos and Recuro, both the companies will jointly develop an advanced recycling facility at Ineos’ Bamble polymer site in Norway. On completion, the project is expected to process up to 33,000 metric tonnes of end-of-life plastic waste annually.

Sulzer has signed an agreement with Highview Power to deliver eight molten salt pumps, five cryopumps and a selection of auxiliary services. The partnership aims to unlock long-duration energy storage at Highview Power’s new facility at Carrington, Manchester, and at other future facilities across the UK.

With an aim to enhance domestic manufacturing of key medicines in the USA and cut dependence on foreign imports, President Donald Trump has threatened a 100 % tariff on branded or patented drug imports for companies not building plants on American soil. The Trump administration has also identified roughly 26 critical medicines and intends to maintain a 6-month supply of APIs for these critical drugs. In addition to this, 17 drug companies have also been pressed to bring U.S. prescription prices in line with those in peer countries, and many have responded with both price cuts and large U.S. investment pledges.

The San Francisco Public Utilities Commission has decided to upgrade the San Francisco wastewater facility with a 1-billion-dollar Southeast Treatment Plant Nutrient Reduction Project. Jacobs has been awarded the design-build contract for this project.

Eneos has recently inaugurated its new demonstration plant which produces methylcyclohexane using its proprietary low-cost ‘electrochemical synthesis of organic hydride’ method.